Abstract
Single-cell and risk gene analysis of children with undifferentiated colitis, Crohn's disease, and ulcerative colitis identifies common underlying mechanisms of pathogenesis and reveals the potential therapeutic benefit of modulating cAMP signaling via the drug dipyridamole.
Original language | English |
---|---|
Pages (from-to) | 1160-1176.e24 |
Journal | Cell |
Volume | 179 |
Issue number | 5 |
DOIs | |
Publication status | Published - 14 Nov 2019 |
Externally published | Yes |
Keywords
- CASP7
- CD39
- PDE4B
- TNF
- cAMP
- dipyridamole
- pediatric-onset colitis and IBD
- platelet
- risk genes
- single-cell RNA expression